Research graph
References from Design and evaluation of a breath-synchronized smart vibrating mesh nebulizer: from instrumentation to human pharmacokinetics. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
A review of respiratory anatomical development, air flow characterization and particle deposition
10.3390/ijerph17020380 · 2020 · External reference
Drug related hospital admissions; a systematic review of the recent literatures
10.29252/beat-070401 · 2019 · External reference
Breath and beyond: advances in nanomedicine for oral and intranasal aerosol drug delivery
10.3390/ph17121742 · 2024 · External reference
Inhaled opioids for cancer pain relief: a narrative review
10.1097/md.0000000000028921 · 2022 · External reference
The history, current state and perspectives of aerosol therapy
10.2478/acph-2022-0017 · 2022 · External reference
Gene therapy in cystic fibrosis
10.1378/chest.120.3_suppl.124s · 2001 · External reference
Inhaled insulin–a new therapeutic option in the treatment of diabetes mellitus
10.1517/14656566.4.2.191 · 2003 · External reference
Advances in pulmonary drug delivery systems and inhalation formulations
10.1007/s11095-023-03534-9 · 2023 · External reference
Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta
10.1186/s13613-022-01068-8 · 2022 · External reference
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children
2022 · External reference
Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations
10.1056/nejmoa1714257 · 2018 · External reference
Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model
10.1186/s12931-016-0395-7 · 2016 · External reference
Mechanisms of pharmaceutical aerosol deposition in the respiratory tract
10.1208/s12249-014-0092-0 · 2014 · External reference
Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands
10.1186/s12890-016-0234-0 · 2016 · External reference
Aerosol particle design to promote targeting in the respiratory tract
10.1016/j.ejps.2025.107350 · 2025 · External reference
Effect of nebuliser and patient interface type on fugitive medical aerosol emissions in adult and paediatric patients
10.1016/j.ejps.2023.106474 · 2023 · External reference
Fill volume, humidification and heat effects on aerosol delivery and fugitive emissions during noninvasive ventilation
10.1016/j.jddst.2017.04.026 · 2017 · External reference
Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19
10.1016/j.rmed.2020.105987 · 2020 · External reference
Guidance on nebulization during the current COVID-19 pandemic
10.1016/j.rmed.2020.106236 · 2021 · External reference
Assessment of metered dose inhaler (mdi) vs mdi and spacer–impact on patient, health care system, and the environment
10.1016/j.chest.2023.07.3374 · 2023 · External reference
Randomized controlled trial of a breath-activated nebulizer in patients with exacerbation of COPD
10.4187/respcare.01609 · 2012 · External reference
Spacers and valved holding chambers-the risk of switching to different chambers
10.1016/j.jaip.2019.12.035 · 2020 · External reference
Unresolved reference
External reference
Nebulized therapies in COPD: past, present, and the future
10.2147/copd.s252435 · 2020 · External reference
The I-neb adaptive aerosol delivery system enhances delivery of alpha1-antitrypsin with controlled inhalation
10.1089/jamp.2009.0793 · 2010 · External reference
Clinical controversies in aerosol therapy for infants and children
10.4187/respcare.04137 · 2015 · External reference
In vitro comparison between inspiration synchronized and continuous vibrating mesh nebulizer during trans-nasal aerosol delivery
10.1186/s40635-020-0293-7 · 2020 · External reference
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
10.1016/s2213-2600(20)30511-7 · 2021 · External reference
Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer
10.1208/pt040454 · 2003 · External reference
Cooling the NGI - an approach to size a nebulised aerosol more accurately
2008 · External reference
Are we overlooking persistent small airways dysfunction in community-managed asthma?
10.1016/j.anai.2012.06.022 · 2012 · External reference
Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
10.2147/copd.s146822 · 2017 · External reference
Aerosol delivery during spontaneous breathing with different types of nebulizers- in vitro/ex vivo models evaluation
10.1016/j.pupt.2017.12.006 · 2018 · External reference
Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric
10.4187/respcare.04490174 · 2004 · External reference
Influence of nebulizer type with different pediatric aerosol masks on drug deposition in a model of a spontaneously breathing small child
10.4187/respcare.01652 · 2012 · External reference
Effect of a nebulizer holding chamber on aerosol delivery
10.4187/respcare.06061 · 2018 · External reference
Improving pulmonary delivery of budesonide suspensions nebulized with constant-output vibrating mesh nebulizers by using valved holding chamber
10.3390/pharmaceutics17060696 · 2025 · External reference
Breath-actuated nebulizers for asthma and chronic obstructive pulmonary disease exacerbation: a monte carlo simulation demonstrating national cost savings and length of stay reduction
2025 · External reference
Randomized clinical trial of nebulized fentanyl citrate versus i.v. fentanyl citrate in children presenting to the emergency department with acute pain
10.1197/j.aem.2007.06.036 · 2007 · External reference
Developmental progress and future potential for inhaled biologics in the treatment of respiratory diseases
10.1007/s40265-026-02336-8 · 2026 · External reference
Inhaled nucleic acid delivery systems for the treatment of pulmonary interstitial diseases: challenges and opportunities
10.1016/j.apsb.2025.12.047 · 2026 · External reference
Futility of current urine salbutamol doping control
10.1111/bcp.13619 · 2018 · External reference
Model-based meta-analysis of salbutamol pharmacokinetics and practical implications for doping control
10.1002/psp4.12773 · 2022 · External reference
Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma
10.1016/s0149-2918(03)80108-x · 2003 · External reference
Risk of pneumonia in obstructive lung disease: a real-life study comparing extra-fine and fine-particle inhaled corticosteroids
10.1371/journal.pone.0178112 · 2017 · External reference
Not all asthma inhalers are the same: factors to consider when prescribing an inhaler
10.4104/pcrj.2009.00029 · 2009 · External reference
Can 'extrafine' dry powder aerosols improve lung deposition?
10.1016/j.ejpb.2015.07.016 · 2015 · External reference
Small airway dysfunction and poor asthma control: a dangerous liaison
10.1186/s12948-021-00147-8 · 2021 · External reference
The relevance of targeting treatment to small airways in asthma and COPD
10.4187/respcare.07237 · 2020 · External reference
Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation
10.1183/09031936.00006211 · 2011 · External reference
Immunohistopathologic localization of P. aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration
10.1164/ajrccm/140.6.1650 · 1989 · External reference
Immunohistologic quantification of P. aeruginosa in the tracheobronchial tree from patients with cystic fibrosis
10.3109/15513819509027007 · 1995 · External reference
Dry powder inhalation for lung delivery in cystic fibrosis
10.3390/pharmaceutics15051488 · 2023 · External reference
Effects of membrane vibration on performance of nebulization
2015 · External reference
Study on the influencing factors of the atomization rate in a piezoceramic vibrating mesh atomizer
10.3390/app10072422 · 2020 · External reference
Investigation of droplet size distribution for vibrating mesh atomizers
10.1016/j.jaerosci.2022.106072 · 2022 · External reference
A new cymbal-shaped high power microactuator for nebulizer application
10.1016/j.mee.2009.05.036 · 2010 · External reference
Characterization of vibrating mesh aerosol generators
10.4209/aaqr.2018.11.0436 · 2019 · External reference
Reducing aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the international society of aerosols in medicine
10.1089/jamp.2020.1615 · 2020 · External reference
Risk of transmitting coronavirus disease 2019 during nebulizer treatment: a systematic review
10.1089/jamp.2020.1659 · 2021 · External reference
Asthma risk and occupation as a respiratory therapist
10.1164/ajrccm/148.3.671 · 1993 · External reference
Occupational risk factors and asthma among health care professionals
10.1164/rccm.200609-1331oc · 2007 · External reference
Unresolved reference
External reference
Mitigating fugitive aerosols during aerosol delivery via high-flow nasal cannula devices
10.4187/respcare.09589 · 2022 · External reference
Influence of aerosol mask design on fugitive aerosol concentrations during nebulization
10.4187/respcare.10578 · 2023 · External reference
The influence of fluid physicochemical properties on vibrating-mesh nebulization
10.1016/j.ijpharm.2007.02.035 · 2007 · External reference
Performance of the vibrating membrane aerosol generation device: aeroneb micropump nebulizer
10.1089/jam.2007.0622 · 2007 · External reference
Fundamentals of aerosol therapy in critical care
10.1186/s13054-016-1448-5 · 2016 · External reference
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary
10.1164/ajrccm.163.5.2101039 · 2001 · External reference
Managing asthma in adolescents and adults: 2020 asthma guideline update from the national asthma education and prevention program
10.1001/jama.2020.21974 · 2020 · External reference
